Stephens Consulting’s Replimune Group REPL Stock Holding History

Stephens Consulting’s Portfolio REPL Stock Details REPL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-35	Closed	-$342	–	1818
2025 Q1	$342	Buy	+35	New	+$433	﹤0.01%	1382

Other funds holding REPL

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Stephens Consulting's REPL Position: Q2 2025 in Review

Stephens Consulting sold out of Replimune Group (REPL) in Q2 2025, closing a stake of 35 shares — an estimated $342 sold.

Stephens Consulting first reported a position in REPL in Q1 2025 and held it in 1 quarter. The position peaked at $342 in Q1 2025. 174 funds tracked by Wall St. Rank hold REPL as of Q2 2025.

Stephens Consulting reported no remaining Replimune Group position as of Q2 2025 after selling out during the quarter.
Stephens Consulting sold 35 Replimune Group shares in Q2 2025, an estimated $342.
Stephens Consulting first reported a position in Replimune Group in Q1 2025 and held it in 1 quarter.
Stephens Consulting's Replimune Group position peaked at $342 in Q1 2025.
174 funds tracked by Wall St. Rank held Replimune Group as of Q2 2025.

Based on Stephens Consulting's 13F filing for Q2 2025, filed 25 Jul 2025.